Altavion Oy: Sale of Albiox Oy to Indutrade AB
Eversheds acted as advisor to Altavion Oy in the sale of its subsidiary Albiox Oy to Indutrade AB (Nasdaq Stockholm: INDT), a Swedish serial acquirer of technology and industrial businesses. Albiox Oy supplies products, equipment and tailored value-added services to the pharmaceutical, research and diagnostics sectors, with a product range covering syringes, needles, packaging solutions and specialty reagents for demanding sterile cleanroom work. The company is a strong addition to Indutrade’s Life Science business area, complementing the Finnish company Labema Oy, which Indutrade acquired in June 2023.
Our team supported Altavion’s shareholders throughout the process, from approaching prospective buyers on behalf of the company through to due diligence and negotiation of the transaction documentation.
Our work covered both financial and legal advisory services, including buyer contact and competitive process management, maintaining the data room, assisting with the seller’s financial and legal due diligence, drafting the completion-related documentation, and negotiating the share purchase agreement and its schedules. The matter was handled by Henri Steiner, Olli Iirola and Sanni Tirkkonen on the legal advisory side, together with Henri Falck and Amos Iirola on the financial advisory side.
Key contacts
Henri Falck
M&A Director
Henri Falck specializes in commercial and strategic advisory for corporate and ownership transactions at Eversheds. He has extensive buy-side experience in private equity and has worked throughout his career with technology and software companies operating under the SaaS business model. At Eversheds, in addition to M&A transactions, Henri also advises clients on ownership arrangements related to growth financing.
